Sociedad Química y Minera de Chile (SQM) Is Down 5.5% After Strong Q1 Beat And Higher Lithium Guidance

Sociedad Quimica y Minera de Chile

Sociedad Quimica y Minera de Chile

SQM

0.00

  • Sociedad Química y Minera de Chile S.A. recently held a board meeting where Hernán Büchi Buc was appointed Vice Chairman and reported first-quarter 2026 results showing sales of US$1,760.11 million and net income of US$364.72 million, both higher than a year earlier.
  • The combination of stronger earnings, higher earnings per share from continuing operations, and increased lithium sales volumes has reinforced the company’s role as a key supplier in a tight lithium market.
  • We’ll now examine how this strong first-quarter performance and raised sales volume guidance could influence Sociedad Química y Minera de Chile’s investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 14 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Sociedad Química y Minera de Chile Investment Narrative Recap

To own Sociedad Química y Minera de Chile, you need to believe its lithium, iodine, and specialty chemical portfolio can stay profitable despite commodity and regulatory swings. The key short term catalyst is execution on elevated lithium sales volumes, which Q1 2026’s stronger earnings and guidance upgrade directly support. The biggest risk remains that lithium price volatility and potential oversupply could quickly reverse this earnings strength; the latest results do not remove that concern, but they do reduce near term pressure.

The most relevant recent development is the Q1 2026 earnings release, with sales of US$1,760.11 million and net income of US$364.72 million, both higher than a year earlier. This strong quarter, alongside higher lithium volumes and raised full year sales volume guidance, feeds directly into the main catalyst: SQM’s ability to monetize its capacity in what appears to be a tight lithium market, while still facing execution and regulatory risks around major Chilean projects.

Yet, investors should also weigh the risk that lithium price volatility and future supply growth could still pressure SQM’s margins and returns, which is something you should be aware of...

Sociedad Química y Minera de Chile's narrative projects $6.5 billion revenue and $1.9 billion earnings by 2028. This requires 15.4% yearly revenue growth and about a $1.4 billion earnings increase from $477.5 million today.

Uncover how Sociedad Química y Minera de Chile's forecasts yield a $75.33 fair value, in line with its current price.

Exploring Other Perspectives

SQM 1-Year Stock Price Chart
SQM 1-Year Stock Price Chart

Some of the lowest ranked analysts were assuming only about 3 percent annual revenue growth to roughly US$5.8 billion by 2029 and a much lower future valuation multiple, so compared with today’s strong Q1 numbers and higher volume guidance their view looks far more pessimistic and highlights how differently you and other investors might frame SQM’s lithium price and regulatory risks.

Explore 6 other fair value estimates on Sociedad Química y Minera de Chile - why the stock might be worth as much as 43% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Sociedad Química y Minera de Chile research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Sociedad Química y Minera de Chile research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Sociedad Química y Minera de Chile's overall financial health at a glance.

Looking For Alternative Opportunities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

  • AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
  • Rare earth metals are the new gold rush. Find out which 26 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.